XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive (Loss) Income
Non- controlling Interest
Balance, beginning of year (in shares) at Dec. 31, 2020   53,427,234          
Balance, beginning of period at Dec. 31, 2020 $ 2,594,111 $ 6 $ (303,614) $ 854,301 $ 2,188,191 $ (146,065) $ 1,292
Balance, beginning of period (in shares) at Dec. 31, 2020     (2,034,012)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options and vesting of RSU's and PSU's (in shares)   262,462          
Exercise of stock options and vesting of RSUs and PSUs 8,727     8,727      
Common stock issued under employee stock purchase plan (in shares)   15,071          
Common stock issued under employee stock purchase plan 2,700     2,700      
Purchased common stock (in shares)   (399,282) (399,282)        
Purchased common stock (78,071)   $ (78,071)        
Stock-based compensation 28,536     28,536      
Net income 212,598       213,329   (731)
Foreign currency translation adjustments and other (28,921)         (28,853) (68)
Unrealized gain (loss) on derivatives, net of tax 165         165  
Balance, end of period (in shares) at Sep. 30, 2021   53,305,485          
Balance, end of period at Sep. 30, 2021 2,739,845 $ 6 $ (381,685) 894,264 2,401,520 (174,753) 493
Balance, end of period (in shares) at Sep. 30, 2021     (2,433,294)        
Balance, beginning of year (in shares) at Jun. 30, 2021   53,491,889          
Balance, beginning of period at Jun. 30, 2021 2,706,280 $ 6 $ (345,345) 883,546 2,326,118 (159,407) 1,362
Balance, beginning of period (in shares) at Jun. 30, 2021     (2,233,789)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options and vesting of RSU's and PSU's (in shares)   13,101          
Exercise of stock options and vesting of RSUs and PSUs 860     860      
Purchased common stock (in shares)   (199,505) (199,505)        
Purchased common stock (36,340)   $ (36,340)        
Stock-based compensation 9,858     9,858      
Net income 74,699       75,402   (703)
Foreign currency translation adjustments and other (15,558)         (15,392) (166)
Unrealized gain (loss) on derivatives, net of tax 46         46  
Balance, end of period (in shares) at Sep. 30, 2021   53,305,485          
Balance, end of period at Sep. 30, 2021 $ 2,739,845 $ 6 $ (381,685) 894,264 2,401,520 (174,753) 493
Balance, end of period (in shares) at Sep. 30, 2021     (2,433,294)        
Balance, beginning of year (in shares) at Dec. 31, 2021 53,010,265 53,010,265          
Balance, beginning of period at Dec. 31, 2021 $ 2,747,221 $ 6 $ (438,503) 908,423 2,466,607 (189,951) 639
Balance, beginning of period (in shares) at Dec. 31, 2021     (2,777,981)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options and vesting of RSU's and PSU's (in shares)   156,640          
Exercise of stock options and vesting of RSUs and PSUs 19     19      
Common stock issued under employee stock purchase plan (in shares)   29,177          
Common stock issued under employee stock purchase plan 2,334     2,334      
Purchased common stock (in shares)   (3,802,440) (3,802,440)        
Purchased common stock (382,885)   $ (382,885)        
Stock-based compensation 29,201     29,201      
Net income 203,657       202,804   853
Foreign currency translation adjustments and other (16,921)         (16,992) 71
Purchase of non-controlling interests (2,500)     (937)     (1,563)
Unrealized gain (loss) on derivatives, net of tax $ 383         383  
Balance, end of period (in shares) at Sep. 30, 2022 49,393,642 49,393,642          
Balance, end of period at Sep. 30, 2022 $ 2,580,509 $ 6 $ (821,388) 939,040 2,669,411 (206,560) 0
Balance, end of period (in shares) at Sep. 30, 2022     (6,580,421)        
Balance, beginning of year (in shares) at Jun. 30, 2022   50,206,255          
Balance, beginning of period at Jun. 30, 2022 2,640,351 $ 6 $ (750,109) 930,950 2,593,147 (134,778) 1,135
Balance, beginning of period (in shares) at Jun. 30, 2022     (5,760,999)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options and vesting of RSU's and PSU's (in shares)   6,809          
Exercise of stock options and vesting of RSUs and PSUs 265     265      
Purchased common stock (in shares)   (819,422) (819,422)        
Purchased common stock (71,279)   $ (71,279)        
Stock-based compensation 8,762     8,762      
Net income 76,698       76,264   434
Foreign currency translation adjustments and other (71,839)         (71,833) (6)
Purchase of non-controlling interests (2,500)     (937)     (1,563)
Unrealized gain (loss) on derivatives, net of tax $ 51         51  
Balance, end of period (in shares) at Sep. 30, 2022 49,393,642 49,393,642          
Balance, end of period at Sep. 30, 2022 $ 2,580,509 $ 6 $ (821,388) $ 939,040 $ 2,669,411 $ (206,560) $ 0
Balance, end of period (in shares) at Sep. 30, 2022     (6,580,421)